drugset / Trial / NCT02382510

Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics

NCT02382510

Phase 2 Completed 59 enrolled Theron Pharmaceuticals, Inc.
RandomizedCrossoverTriple-blindTreatment

Summary

This multiple ascending dose study is to determine the safety and bronchodilator activity of TRN-157 in 59 mild and moderate asthmatics.

Timeline

Start
2015-04
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject TRN-157 Unknown
Comparator Tiotropium Other / unclassified

Indications